Home › NDC Lookup › Ingredients › Cobra Venom (Naja Naja) 2X, Hemp Extract... › 73002-0222-02
🧴image loading
(from DailyMed)

PAIN RELIEF SNAKE VENOM AND HEMP cobra venom (Naja naja) 2X, hemp extract (Cannabis sativa) 1X, moccasin venom (A.piscivorus) 4X .1 mg/mL; 15.7 mg/mL; .001 mg/mL Lotion, 56 mL — NDC 73002-222-02 (Billing 73002-0222-02)

by Green Earth Health Inc. · 56 mL in 1 BOTTLE

This is a package of 56 mL of PAIN RELIEF SNAKE VENOM AND HEMP cobra venom (Naja naja) 2X, hemp extract (Cannabis sativa) 1X, moccasin venom (A.piscivorus) 4X .1 mg/mL; 15.7 mg/mL; .001 mg/mL Lotion from Green Earth Health Inc., no longer marketed (first marketed Sep 2020), no longer in the FDA NDC Directory, this package's marketing ended Sep 2026. It is this product's only package size.

NDC 73002-0222-02
🏷️ FDA NDC (as labeled) 73002-222-02 billing pads the product segment with a zero
OTC Discontinued Non-controlled ⚠ Discontinued by firm ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 73002-222-02 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
73002 labeler · 222 product · 02 package
Package marketed since
Sep 1, 2020
Package marketing ended
Sep 30, 2026
Sample package
No — commercial package
Barcode (UPC-A, from the NDC)
3 7300222202 3
FDA record last changed
Aug 27, 2026
⚠️
Excluded from the active FDA NDC Directory. The labeler reported this product as discontinued, so it is excluded from the active NDC Directory. The listing was last certified through Sep 2026. A label may still appear on DailyMed, but the NDC is no longer in the current FDA NDC Directory. Search the FDA NDC Directory ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 73002-222-02
Product NDC 73002-222
11-digit billing NDC 73002022202
UNII ZZ4AG7L7VM, 8X454SZ22D, X9V1Q8U150
SPL Set ID f27d8c5a-2e1c-48d1-a2c7-029c5cbd5a88
DEA schedule Non-controlled
Marketing category UNAPPROVED HOMEOPATHIC
Marketing status Discontinued
FDA listing status Discontinued by firm (certified through Sep 2026)
Marketing start 2020-09-01
Marketing end 2026-09-30
Route TOPICAL
Dosage form LOTION
Substance NAJA NAJA VENOM; CANNABIS SATIVA SUBSP. SATIVA FLOWERING TOP; AGKISTRODON PISCIVORUS VENOM
Why two NDCs? The FDA registers this code as 73002-222-02 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 73002-0222-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

This is a homeopathic lotion applied to the skin that contains highly diluted cobra venom, moccasin venom, and hemp extract. In homeopathic practice, these ingredients are traditionally used for topical pain and discomfort, though homeopathic products are marketed based on traditional use rather than clinical testing. This product is not evaluated by the FDA for effectiveness. Homeopathic remedies operate under different principles than conventional medicine and are not proven to work by standard scientific standards.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
73002-0222-02 You're viewing this Main listing 56 mL in 1 BOTTLE 2020-09-01 Sep 30, 2026 Discontinued by firm

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Pain Relief Snake Venom And Hemp .1 mg/mL; 15.7 mg/mL; .001 mg/mLthis 73002-0222-02 Green 56 ml — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Sep 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerGreen Earth Health Inc.
Labeler code73002
First marketedSep 2020
Product typeHuman Otc Drug
Portfolio10 products on file

More NDCs from Green Earth Health Inc. labeler code 73002

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

Indication: Temporarily relieves pain associated with neuropathy, periodic neuralgia, neck & back pain

⏱️ Dosage and Administration 60 words ▾

Directions For Use: Liberally apply lotion to affected area and rub into joints. Use 3-4 times per day for the first week. Use as needed thereafter to relieve discomfort. Use no more than 4 times per day. Allow several days for product to take maximum effect. Use within 60 days from opening. Store at 50° to 75°F (10°C to 24°C)

⚠️ Warnings 92 words ▾

Warnings: • For external use only . Not for use on open wounds. • If symptoms persist or worsen, discontinue use, seek medical attention. • Avoid contact with eyes. If product gets into eyes, flush with water, seek medical attention. • If rash, redness, irritation or itching occurs, discontinue use. • If pregnant or breastfeeding ask a health professional before use. • If diagnosed with psychiatric or mood disorder, seek medical advice before use. • If swallowed, get medical help or contact a Poison Center. • Keep out of reach of children.

🧪 Active Ingredient 40 words ▾

Active Ingredients Purpose Cobra venom (Naja naja) 2X 1% (0.1mg) HPUS Analgesic Hemp extract (Cannabis sativa) 1X 7%(15.7mg)HPUS Anti-inflammatory Moccasin venom (A.piscivorus) 4X 1%(0.001mg) HPUS Analgesic Approximately 56 applications per container Reference: the Homeopathic Pharmacopoeia of the United States (HPUS)

🧪 Inactive Ingredients 17 words ▾

Inactive Ingredients: Ethylglycerin, C13-14 isoparaffin, laureth-7, purified water, phenoxyethanol, polyacrylamide, tetrasodium EDTA, virgin olive oil, vitamin E

📄 Package Label / Principal Display Panel 4 words ▾

Product label image description

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product Homeopathic listing No longer marketed (per FDA listing data)

About homeopathic listings

PAIN RELIEF SNAKE VENOM AND HEMP cobra venom (Naja naja) 2X, hemp extract (Cannabis sativa) 1X, moccasin venom (A.piscivorus) 4X .1 mg/mL; 15.7 mg/mL; .001 mg/mL LOTION is listed under the homeopathic marketing category. An NDC listing in this category does not by itself establish FDA approval, and FDA does not evaluate homeopathic products for effectiveness. This page reports the listing data as published.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Homeopathic". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
What does the discontinued status mean for this NDC?
The labeler reported a marketing end date (or the listing was delisted), so this specific package is no longer actively marketed. Remaining stock may still be dispensed for a time, and the NDC stays valid for historical records and claims — but data feeds (pricing, labeling) typically stop updating for it. Other package sizes or other manufacturers' versions of the same medication may still be marketed — see the equivalents section where available.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Who lists this product with the FDA?
Green Earth Health Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 73002-0221-01 · Green 73002-0231-01 · Green →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.